1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prevalence and functional impact of parkinsonian signs in older adults from the Good Aging in Skåne study : Parkinsonian signs in older adults
(
- Contribution to journal › Article
- 2021
-
Mark
How to detect late-onset inborn errors of metabolism in patients with movement disorders - A modern diagnostic approach
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
(
- Contribution to journal › Letter
- 2016
-
Mark
Autosomal dominant Parkinson's disease caused by SNCA duplications.
(
- Contribution to journal › Article
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141(
- Contribution to journal › Published meeting abstract
-
Mark
Tobacco increases dystonia risk but may ameliorate symptoms
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.137-138(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review